Table 4.

Relation between laboratory variables, vWFa, CD14 and CD11b and the development of TE in thalassemic patients.

	No history of TE (n=33)		History of TE (n=7)		p-value¶
Variable	Median	interquartile range	Median	Interquartile range
SGPT (IU/L)	40	31–7070	51–90	0.226
SGOT (IU/L)	50	31–6557	48–110	0.200
Urea (mg/dL)	26.0	21.0–29.0	25.0	25.0–27.0	0.900
Creatinine (mg/mL)	0.7	0.6–0.80.7	0.6–0.8	0.704
Hemoglobin (g/dL)	6.7	5.8–0.85.6	5.2–7.0	0.219
WBCs (x1000/mm3)	8.70	6.40–12.00	15.00	8.00–38.00	0.139
Platelets (x1000/mm3)	400	300–520	949	800–1000	<0.001
vWFa (IU/dL)	3.50	1.80–5.50	5.00	1.10–8.00	<0.05
CD14 (μg/ml)	5.15	3.10–7.86	2.80	2.33–4.91	0.067
CD11b (μg/mL)	76.20	64.80–83.50	54.90	46.50–70.90	0.075

Data are median and interquartile range (interquartile range)

^¶Wilcoxon rank sum test.